Page 35 - பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை இல் கால்வெஸ்டன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer, Moderna vaccines may be less effective against B1351 variant

Lab studies point to lower protection against the variant first identified in South Africa.

South africaUnited kingdomAstrazeneca oxfordNational institute of allergyUniversity of texas medical branch in galvestonNew england journalTexas medical branchNational instituteInfectious diseasesஒன்றுபட்டது கிஂக்டம்தேசிய நிறுவனம் ஆஃப் ஒவ்வாமைபல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை இல் கால்வெஸ்டன்புதியது இங்கிலாந்து இதழ்டெக்சாஸ் மருத்துவ கிளைதேசிய நிறுவனம்தொற்று நோய்கள்

SA variant takes on the vaccine race

SA variant takes on the vaccine race
biznews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznews.com Daily Mail and Mail on Sunday newspapers.

South africaSouth africanSouth africansJustin rowe robertsNaomi kresgeRobert langrethUniversity of texas medical branch at galvestonNational institute of allergyDiscovery healthSouth africa likeTexas medical branchNew england journalNational instituteInfectious diseasesஜஸ்டின் ரோ ராபர்ட்ஸ்நவோமி க்ரஸ்கே

Pfizer shot produces fewer antibodies versus South Africa strain

Pfizer shot produces fewer antibodies versus South Africa strain
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

South africaSouth africanNational institute of allergyAstrazeneca plcUniversity of texas medical branch at galvestonPfizer incModerna incNovavax incSouth africa likeTexas medical branchNew england journalNational instituteInfectious diseasesதேசிய நிறுவனம் ஆஃப் ஒவ்வாமைபல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை இல் கால்வெஸ்டன்ஃபைசர் இன்க்

Pfizer Shot Elicits Fewer Antibodies to South Africa Strain

Pfizer Shot Elicits Fewer Antibodies to South Africa Strain Bloomberg 2/18/2021 Naomi Kresge and Robert Langreth © Photographer: Michael Ciaglo/Getty Images Pharmacy technicians prepare doses of the Pfizer-BioNTech vaccine at a mass COVID-19 vaccination event on January 30, 2021 in Denver, Colorado. (Bloomberg) Pfizer Inc. and BioNTech SE’s Covid-19 vaccine stimulated roughly two-thirds lower levels of neutralizing antibodies against the South African variant of the coronavirus in a lab study. The Pfizer results are part of tests of its vaccine against a lab-created virus that had all the mutations found in the South African variant, which is thought to spread faster than earlier versions. The study released Wednesday showed reduced neutralization of the South Africa-like virus by blood from people who had been immunized with the Pfizer-BioNTech vaccine. The companies expect their vaccine will still work against the variant.

United statesSouth africaSouth africanBiontech covidMichael ciaglo gettyJohn nkengasongSam fazeliNational institute of allergyWorld health organizationAfrica centers for diseaseBloomberg pfizer incAstrazeneca plcUniversity of texas medical branch at galvestonModerna incNovavax incGetty images pharmacy

Artificial intelligence trains doctors to be more empathetic to people

In an age of telemedicine, doctors are turning to virtual patients powered by artificial intelligence to learn how to better interact with real people.

City ofUnited kingdomUnited statesLos angelesAlex youngJack boulterSinai medical centerUniversity of texas medical branch in galvestonHealth education centerTexas medical branchCedar sinaiநகரம் ஆஃப்ஒன்றுபட்டது கிஂக்டம்ஒன்றுபட்டது மாநிலங்களில்லாஸ் ஏஞ்சல்ஸ்அலெக்ஸ் இளம்